PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 3, 2026Journal of Brown Hospital Medicine0 citationsOpen Access

Unprovoked Venous Thromboembolism in a Patient with a Small PNH Clone: A Therapeutic Dilemma

KBKavya BalusuDMDhatri MalipeddiPPPradyumna D. Phatak

Key Points

  • To explore the treatment dilemma of acute thrombotic events in a patient with a small PNH clone.
  • Case report of a 69-year-old female with PNH presenting with unprovoked VTE.
  • Flow cytometry used to assess PNH clone size.
  • Clinical assessment of thrombosis management options.
  • Patient had a small PNH clone without hemolysis.
  • Managed with anticoagulation alone.
  • Highlights challenges in treating VTE in PNH cases.

Abstract

Paroxysmal nocturnal hemoglobinuria (PNH) is a rare clonal hematopoietic stem cell disorder commonly presenting with hemolytic anemia and thrombosis. Treatment of acute thrombotic events usually involves a combination of complement inhibitor therapy and anticoagulation. We report the case of a 69-year-old female with history of PNH in spontaneous remission who presented nearly two decades later with unprovoked venous thromboembolism (VTE). Flow cytometry detected a small PNH without evidence of hemolysis, creating a dilemma regarding the need for complement inhibitor therapy. She was ultimately treated with anticoagulation alone. This case highlights the unknown aspects of the natural history of PNH and the challenges in managing venous thromboembolism in patients with persistent small PNH clones.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Balusu et al. (2026) studied this question.

synapsesocial.com/papers/69cf5ea85a333a821460d1f9https://doi.org/10.56305/001c.157720
Ask AI
Helpful
Bookmark
Share
View Full Paper